American Herbal Products Association (AHPA) > News > Alerts > Market Alerts

Market Alerts

  News   >   Alerts   >   Market Alerts

Market Alerts

July 2022

June 2022

May 2022

April 2022

February 2022

November 2021

  • SCNM Dedicates Ric Scalzo Institute of Botanical Research

    • August 2021

    July 2021

    March 2021

    February 2021

    November 2020

    October 2020

    September 2020

    August 2020

    July 2020

    June 2020

    April 2020

    February 2020

    January 2020

  • Sabinsa's parent company Sami Labs breaks ground on $30 million state of the art production facility
  • Unstoppable Moms Across America launches new Gold Standard to shift the marketplace for a healthier planet
  • Draco Achieves Safe Quality Food (SQF) certification of its manufacturing facilities

    • August 2019

    June 2019

    May 2019

    March 2019

    February 2019

    January 2019

    December 2018

    November 2018

    October 2018

    September 2018

    August 2018

    July 2018

    May 2018

    April 2018

    March 2018

    February 2018

    January 2018

    December 2017

    November 2017

    October 2017

    September 2017

    August 2017

    July 2017

    June 2017

    Happy Birthday DSHEA!

    AHPA celebrates the 25th Anniversary of DSHEA

    Guidance: Federal Labeling Requirements for Herbal Dietary Supplements

    Updated to reflect changes from May 2016 Final Rule revising FDA’s nutrition labeling regulations

    AHPA has revised it's labeling guidance for herbal dietary supplements to cover updated nutrition labeling requirements for foods and dietary supplements that are scheduled to take effect January 1, 2020 for manufacturers with $10 million or more in annual sales and January 1, 2021 for smaller manufacturers.
    Dietary supplement recalls are relatively infrequent according to recent FDA data

    Dietary supplement recalls are relatively infrequent according to recent FDA data

    Two percent of more than 800 recalls initiated in 2019 involved dietary supplement products

    Recall data from the Food and Drug Administration (FDA) shows that 14 of 803 (1.7 percent) recorded recalls initiated in 2019 involved dietary supplements, and among these, three were Class I recalls (the most serious recall class), according to an article published in the August 2019 AHPA Report.
    CO Gov Jared Polis charts course for CBD and hemp innovation at sold-out AHPA Supplement Congress

    CO Gov Jared Polis charts course for CBD and hemp innovation at sold-out AHPA Supplement Congress

    USDA and FDA officials share key information for companies selling hemp-CBD in dietary supplements

    Colorado Governor Jared Polis rallied more than 200 hemp farmers, manufacturers, producers, retailers, and industry professionals during his keynote address to the American Herbal Products Association (AHPA) Hemp-CBD (cannabidiol) Supplement Congress held earlier this month.

    CA Prop 65 Guidance for Hemp Products

    Regulatory and liability implications of Proposition 65 for hemp and hemp-derived products

    AHPA has published Guidance on California Proposition 65 and Hemp Products to educate the hemp industry about the regulatory and liability implications of Proposition 65 for hemp and hemp-derived products, including cannabidiol (CBD), sold in the State of California.
    IADSA update on international supplement regulations

    IADSA update on international supplement regulations

    IADSA July 2019 Newsflash

    China considers adding 5 functional ingredients, including reishi powder and spirulina, to its food raw materials directory, and changes to permitted health food function claims, in this issue of the IADSA Newsflash.

    Sen. Wyden urges HHS-FDA to issue interim final rule for lawful use of CBD in food and dietary supplements

    Sen. Wyden urges HHS-FDA to issue interim final rule for lawful use of CBD in food and dietary supplements

    June 25, 2019: Sen. Wyden's request aligns with AHPA's hemp-CBD advocacy

    Sen. Ron Wyden (D-OR), a co-author of the hemp provisions included in the 2018 Farm Bill, sent letters to Food and Drug Administration (FDA) Commissioner Ned Sharpless and Health & Human Services (HHS) Secretary Alex Azar urging the agencies to promptly create a regulatory pathway to use cannabidiol (CBD) as a food additive and as a dietary ingredient in dietary supplements.

    AHPA President Michael McGuffin presents on CA regulations that impact the supplement industry at ACI Conference

    AHPA provides several resources to help navigate CA regulations

    American Herbal Products Association (AHPA) President Michael McGuffin discussed significant California regulations that impact the dietary supplement industry at the American Conference Institute's (ACI's) seventh annual Legal, Regulatory, and Compliance Forum on Dietary Supplements held in New York City June 18-20.

    AHPA urges USTR to exempt herbal product ingredients from proposed China tariff increases

    June 2019: Herbal ingredients should be excluded from tariff increases because supplements and food play important roles in the health of U.S. consumers

    The American Herbal Products Association (AHPA) urged the U.S. Trade Representative (USTR) to remove herbal product ingredients from a list of Chinese goods that would be subject to a 25 percent ad valorem duty under a recent USTR proposal to increase tariffs on an estimated $300 billion worth of Chinese imports.
    AHPA President Michael McGuffin urges FDA to use existing authority to create legal pathway for CBD products

    AHPA President Michael McGuffin urges FDA to use existing authority to create legal pathway for CBD products

    May 31, 2020: McGuffin recommends FDA issue interim final rule with an accelerated effective date

    American Herbal Products Association (AHPA) President Michael McGuffin urged the Food and Drug Administration (FDA) to use existing authority to quickly create a lawful pathway -- including considering issuing a interim final rule -- for marketing of cannabidiol (CBD)-containing supplements and foods at a public meeting held by FDA in Silver Spring, MD.
    RSS
    12345678910 Last

    2022 Annual Fund Sponsors

    AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.

              
    Address: 8630 Fenton Street, Suite 918, Silver Spring, MD 20910
    Phone: 301.588.1171
    Email: ahpa@ahpa.org
    ©Copyright 2022 AHPA
    Copyright 2024 by American Herbal Products Association (AHPA) | Privacy Statement | Terms Of Use